Akari Therapeutics, Plc announced the appointment of Torsten Hombeck as member of the Company’s executive team. Dr. Hombeck has over two decades of biopharmaceutical industry experience in financial management and strategic planning, including several senior executive positions where he was responsible for finance, strategy, business and corporate development, and commercialization primarily in the U.S. Dr. Hombeck will be based out of Akari’s New York City office and will also be responsible for investor relations and business development.